BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15468685)

  • 1. Therapeutic angiogenesis by autologous bone marrow cell implantation for refractory chronic peripheral arterial disease using assessment of neovascularization by 99mTc-tetrofosmin (TF) perfusion scintigraphy.
    Miyamoto M; Yasutake M; Takano H; Takagi H; Takagi G; Mizuno H; Kumita S; Takano T
    Cell Transplant; 2004; 13(4):429-37. PubMed ID: 15468685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging Angiogenesis Using 99mTc-Macroaggregated Albumin Scintigraphy in Patients with Peripheral Artery Disease.
    Takagi G; Miyamoto M; Fukushima Y; Yasutake M; Tara S; Takagi I; Seki N; Kumita S; Shimizu W
    J Nucl Med; 2016 Feb; 57(2):192-7. PubMed ID: 26541773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans.
    Durdu S; Akar AR; Arat M; Sancak T; Eren NT; Ozyurda U
    J Vasc Surg; 2006 Oct; 44(4):732-9. PubMed ID: 16926085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A clinical study on implantation of autologous bone marrow mononuclear cells after bone marrow stimulation for treatment of lower limb ischemia].
    Gu Y; Zhang J; Qi L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1017-20. PubMed ID: 17140078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells.
    Motukuru V; Suresh KR; Vivekanand V; Raj S; Girija KR
    J Vasc Surg; 2008 Dec; 48(6 Suppl):53S-60S; discussion 60S. PubMed ID: 19084740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous peripheral blood mononuclear cell implantation for patients with peripheral arterial disease improves limb ischemia.
    Ishida A; Ohya Y; Sakuda H; Ohshiro K; Higashiuesato Y; Nakaema M; Matsubara S; Yakabi S; Kakihana A; Ueda M; Miyagi C; Yamane N; Koja K; Komori K; Takishita S
    Circ J; 2005 Oct; 69(10):1260-5. PubMed ID: 16195628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic angiogenesis by bone marrow implantation for critical hand ischemia in patients with peripheral arterial disease: a pilot study.
    Koshikawa M; Shimodaira S; Yoshioka T; Kasai H; Watanabe N; Wada Y; Seto T; Fukui D; Amano J; Ikeda U
    Curr Med Res Opin; 2006 Apr; 22(4):793-8. PubMed ID: 16684440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial.
    Tateishi-Yuyama E; Matsubara H; Murohara T; Ikeda U; Shintani S; Masaki H; Amano K; Kishimoto Y; Yoshimoto K; Akashi H; Shimada K; Iwasaka T; Imaizumi T;
    Lancet; 2002 Aug; 360(9331):427-35. PubMed ID: 12241713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous bone-marrow mononuclear cell implantation in patients with severe lower limb ischaemia: a comparison of using blood cell separator and Ficoll density gradient centrifugation.
    Hernández P; Cortina L; Artaza H; Pol N; Lam RM; Dorticós E; Macías C; Hernández C; del Valle L; Blanco A; Martínez A; Díaz F
    Atherosclerosis; 2007 Oct; 194(2):e52-6. PubMed ID: 16982058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [99mTc-tetrofosmin exercise leg perfusion scintigraphy in arteriosclerosis obliterans (ASO)--assessment of leg ischemia using two phase data acquisition].
    Kijima T; Kumita S; Cho K; Kumazaki T
    Kaku Igaku; 1998 Jun; 35(5):305-13. PubMed ID: 9695463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results.
    Isner JM; Baumgartner I; Rauh G; Schainfeld R; Blair R; Manor O; Razvi S; Symes JF
    J Vasc Surg; 1998 Dec; 28(6):964-73; discussion 73-5. PubMed ID: 9845647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia.
    Kajiguchi M; Kondo T; Izawa H; Kobayashi M; Yamamoto K; Shintani S; Numaguchi Y; Naoe T; Takamatsu J; Komori K; Murohara T
    Circ J; 2007 Feb; 71(2):196-201. PubMed ID: 17251666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia.
    Beeres SL; Bax JJ; Dibbets P; Stokkel MP; Zeppenfeld K; Fibbe WE; van der Wall EE; Schalij MJ; Atsma DE
    J Nucl Med; 2006 Apr; 47(4):574-80. PubMed ID: 16595489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic angiogenesis using bone marrow cells].
    Ikeda U
    Masui; 2007 Nov; 56 Suppl():S6-11. PubMed ID: 18051443
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic angiogenesis for peripheral arterial disease and ischemic heart disease by autologous bone marrow cells implantation].
    Tatsumi T; Matsubara H
    Nihon Rinsho; 2006 Nov; 64(11):2126-34. PubMed ID: 17087307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis facilitated by autologous whole bone marrow stem cell transplantation for Buerger's disease.
    Kim DI; Kim MJ; Joh JH; Shin SW; Do YS; Moon JY; Kim NR; Lim JE; Kim AK; Eo HS; Kim BS; Cho SW; Yang SH; Park CJ; Shim JS
    Stem Cells; 2006 May; 24(5):1194-200. PubMed ID: 16439614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia.
    Matoba S; Tatsumi T; Murohara T; Imaizumi T; Katsuda Y; Ito M; Saito Y; Uemura S; Suzuki H; Fukumoto S; Yamamoto Y; Onodera R; Teramukai S; Fukushima M; Matsubara H;
    Am Heart J; 2008 Nov; 156(5):1010-8. PubMed ID: 19061721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous bone marrow mononuclear cell therapy improves symptoms in patients with end-stage peripheral arterial disease and reduces inflammation-associated parameters.
    Malyar NM; Radtke S; Malyar K; Arjumand J; Horn PA; Kröger K; Freisinger E; Reinecke H; Giebel B; Brock FE
    Cytotherapy; 2014 Sep; 16(9):1270-9. PubMed ID: 24972744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neovascularization induced by autologous bone marrow cell implantation in peripheral arterial disease.
    Esato K; Hamano K; Li TS; Furutani A; Seyama A; Takenaka H; Zempo N
    Cell Transplant; 2002; 11(8):747-52. PubMed ID: 12588106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of autologous bone-marrow cell transplantation on ischemic ulcer in patients with Buerger's disease.
    Saito Y; Sasaki K; Katsuda Y; Murohara T; Takeshita Y; Okazaki T; Arima K; Katsuki Y; Shintani S; Shimada T; Akashi H; Ikeda H; Imaizumi T
    Circ J; 2007 Aug; 71(8):1187-92. PubMed ID: 17652879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.